Home > Boards > US OTC > Biotechs >

Eisai Co., Ltd. (ESALF)

ESALF RSS Feed
Add ESALF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/21/2015 1:37:47 PM - Followers: 0 - Board type: Free - Posts Today: 0

Eisai Co., Ltd. 4-6-10, Koishikawa Bunkyo-ku Tokyo, 112-8088 Japan Phone: 81 3 3817 3700 Website: http://www.eisai.co.jp Eisai Co., Ltd. manufactures and sells pharmaceutical products worldwide. The company offers oncology-related products, such as Halaven, an anticancer agent; Aloxi, an antiemetic agent; and Fragmin, an injectable anticlotting agent, as well as Symbenda/Treakisym, a treatment for low-grade non-Hodgkin's lymphoma and other types of lymphatic cancer. It also provides Aricept, an anti-Alzheimer's agent; Pariet/AcipHex, a proton-pump inhibitor; and Humira, a human anti-TNF-a monoclonal antibody. In addition, the company offers epilepsy products comprising Zonegran, Zebinix, and Fycompa, which are antiepileptic agents; and Inovelon/BANZEL for the treatment of Lennox-Gastaut syndrome, as well as consumer healthcare (over-the-counter) products, which include vitamin B2 preparation Chocola BB Plus. Further, it provides Methycobal, a peripheral neuropathy treatment; Warfarin, an oral anticoagulant; Actonel, an osteoporosis treatment; Selbex for the treatment of gastritis/gastric ulcer; BELVIQ, an antiobesity agent; Stronger Neo-Minophagen C/Glycyron tablets for liver disease/allergic disease treatment; Lyrica, a treatment for postherpetic neuralgia; and Lunesta, a treatment for insomnia. Additionally, the company is involved in the research and development of various products under the areas of oncology, vascular and immunological reaction, gastrointestinal and hepatic disorders, and neurology. It has strategic partnerships with Quintiles Inc.; SFJ Pharma Ltd.; Biogen Idec, Inc.; BioArctic Neuroscience AB; FORMA Therapeutics, Inc.; Epizyme, Inc.; PRISM BioLab Co., Ltd.; and Verastem, Inc. for the discovery and development of various products. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan.
ESALF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ESALF News: Arena completes two Phase 1 trials for once-daily formulation of Belviq 04/10/2015 08:48:57 AM
ESALF News: Merck and Eisai team up in cancer 03/05/2015 07:51:19 AM
ESALF News: Week In Review: Eddingpharm Pays $169 Million For China Rights To Omega-3 Drug 03/01/2015 03:01:13 PM
PostSubject
#1   $ESALF recent news/filings stocktrademan 07/21/15 01:37:47 PM
PostSubject